Clinical trials
Phase 4 Peripheral Vascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 4 |
| 2013 | 1 |
| 2014 | 6 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 5 |
| Unknown status | 5 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Flanders Medical Research Program | 8 |
| Barnsley Hospital | 2 |
| Deutsches Herzzentrum Muenchen | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| Abbott Medical Devices | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Aesculap AG | 1 |
| Arteriogenesis Competence Network | 1 |
| Baker Heart and Diabetes Institute | 1 |
| Colorado Prevention Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Vascular Diseases | 39 |
| Intermittent Claudication | 9 |
| Peripheral Arterial Disease | 9 |
| Coronary Artery Disease | 6 |
| Chronic Limb-Threatening Ischemia | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Atherosclerosis | 4 |
| Diabetes Mellitus | 4 |
| Arterial Occlusive Diseases | 3 |
| Cardiovascular Diseases | 3 |
Trials
Showing 26 to 39 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.